Bcr-abl1-like Acute Lymphoblastic Leukemia

All Approvals Safety alerts Label changes Trial results Research Guidance Withdrawals

CLINICAL_TRIALS trial_result · 2024-03-12
Clinical Trial Update: Combination Chemotherapy in Treating Young Patients With Newly Diagnosed High-Risk B Acute Lymphoblastic Leukemia and Ph-Like TKI Sensitive Mutations [Phase 3]
Phase 3 clinical trial update evaluating combination chemotherapy in young patients with newly diagnosed high-risk B-cell acute lymphoblasti…